海外新闻当前位置:主页 > 海外新闻 > 正文

China Pharma Holdings, Inc. to Present at Two Upcoming Inves

发布时间:2018-11-06 08:23 浏览次数:AG集&#

HAIKOU, Hainan, China, Nov. 27 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) today announced that Mr. Xinhua Wu, CFO of China Pharma, and Mr. Ren Zhang, Vice President of China Pharma, will present at ROTH China -- Phoenix Conference and Annual ICR XChange Asia institutional investor conference.

Mr. Ren Zhang, Vice President of China Pharma, will present at the ROTH China -- Phoenix Conference from 8:00 a.m. to 8:45 a.m. November 30, 2007 at the Royal Palms Resort and Spa, 5200 East Camelback Road, Phoenix, Arizona. The presentation will be broadcast live over the Internet and can be accessed by all interested parties at China Pharma’s website at http://www.chinapharmaholdings.com . Management will host several break-out sessions with investors on both Nov 29th and 30th. For more information about the conference, please visit http://www.rothcapital.com .

Mr. Ren Zhang, Vice President, will present at the Annual ICR XChange Asia institutional investor conference at 1:30 p.m. ET December 5, 2007 at the Reuters Conference Center at Three Times Square in New York City. The presentation will be webcast live at http://www.icrxchange.com . Management will host two break-out sessions with investors the same day. For more information, please visit http://www.icrxchange.com .

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.

For more information, please contact:

Sophia Yu

China Pharma Holdings, Inc.

Tel: +86-898-6681-1730

Email: hps@chinapharmaholdings.com